🇺🇸 FDA
Pipeline program

XPF-010, Placebo to match XPF-010

XPF-010-D302

Phase 3 small_molecule active

Quick answer

XPF-010, Placebo to match XPF-010 for Major Depressive Disorder is a Phase 3 program (small_molecule) at Xenon Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Xenon Pharmaceuticals
Indication
Major Depressive Disorder
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials